Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - Dependent pathway

Diabetes

Volumn 53, Issue 11, 2004, Pages 2921-2930

  Thallas Bonke, Vicki ^a,b   Lindschau, Carsten ^c   Rizkalla, Bishoy ^a   Bach, Leon A ^b   Boner, Geoffrey ^a,d   Meier, Matthias ^c   Haller, Hermann ^c   Cooper, Mark E ^a,b   Forbes, Josephine M ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4,5 DIMETHYL 3 (2 OXO 2 PHENYLETHYL)THIAZOLIUM; ADVANCED GLYCATION END PRODUCT; ALT 11; AMINOGUANIDINE; FIBRONECTIN; GLUCOSE; ISOENZYME; LAMININ; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; PROTEIN KINASE C BETA2; PROTEIN KINASE C EPSILON; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; INTRACELLULAR TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; KIDNEY CORTEX; MALE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 7044231909     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.11.2921     Document Type: Article

References (42)

1. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S: Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group: Diabetes Control and Complications Trial. Diabetes 48:870-880, 1999
2. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91:11704-11708, 1994
3. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
4. Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW: Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939-950, 2002
5. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME: The breakdown of pre-existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes [article online], 2003. Available from http://www.fasebj.org/cgi/content/full/17/12/1762. Accessed 17 July 2003
6. Pfaff IL, Wagner HJ, Vallon V: Immunolocalization of protein kinase C isoenzymes alpha, betaI and betaII in rat kidney. J Am Soc Nephrol 10:1861-1873, 1999
7. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H: Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 56:1737-1750, 1999
8. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN, Pratt LM, Russo LM, Kemp BE, Comper WD, Jerums G: Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 49:87-93, 2000
9. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: possible mediation by glucose. J Clin Invest 83:1667-1675, 1989
10. Meier M, King GL: Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med 5:173-185, 2000
11. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447, 2000
12. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728-731, 1996
13. Meier M, Park JK, Boehne M, Elger M, Leitges M, Haller H, Menne J: Knockout of protein kinase C alpha protects against the development of albuminuria but not renal hypertrophy. Diabetes 52:A50, 2003
14. Duh E, Aiello LP: Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48:1899-1906, 1999
15. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229-2239, 1999
16. Cha DR, Kim NH, Yoon JW, Jo SK, Cho WY, Kim HK, Won NH: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int Suppl 77:S104-S112, 2000
17. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol 278:F676-F683, 2000
18. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation end product receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A 93:11047-11052, 1996
19. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282, 1973
20. Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, Jerums G: Glomerular filtration rate in streptozocin-induced diabetic rats: role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes 39:1182-1190, 1990
21. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G: Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50:627-634, 1996
22. Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD, Izlar C: Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 40:1317-1321, 1994
23. Chamley-Campbell J, Campbell GR, Ross R: The smooth muscle cell in culture. Physiol Rev 59:1-61, 1979
24. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47:1057-1067, 1995
25. Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382:275-278, 1996
26. Liu SH, Wang JH, Fang KT, Lin-Shiau SY: Involvement of protein kinase C in the nitric oxide-mediated peripheral nerve disturbance in endotoxemic rats. Neurosci Lett 259:99-102, 1999
27. Rong J, Qiu H, Wang S: Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats. Chin Med J (Engl) 113:1087-1091, 2000
28. Osicka TM, Yu Y, Lee V, Panagiotopoulos S, Kemp BE, Jerums G: Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin Sci (Colch) 100:249-257, 2001
29. Hovind P, Tarnow L, Oestergaard PB, Parving HH: Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl 75:S56-S61, 2000
30. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12:1448-1457, 2001
31. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
32. Lee BH, Park RW, Choi JY, Ryoo HM, Sohn KY, Kim IS: Stimulation of fibronectin synthesis through the protein kinase C signalling pathway in normal and transformed human lung fibroblasts. Biochem Mol Biol Int 39:895-904, 1996
33. Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim HS, Hwa V, Oh Y, Rosenfeld RG: Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143:1260-1269, 2002
34. Ha TS, Barnes JL, Stewart JL, Ko CW, Miner JH, Abrahamson DR, Sanes JR, Kasinath BS: Regulation of renal laminin in mice with type II diabetes. J Am Soc Nephrol 10:1931-1939, 1999
35. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
36. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 91:9436-9440, 1994
37. Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U: Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46:1881-1887, 1997
38. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
39. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL: Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473-1480, 1997
40. Mueller HK, Fritsche U, Haslinger A, Landgraf R: Glucose-induced fibronectin expression in endothelial cells is mediated by protein kinase C. Exp Clin Endocrinol Diabetes 105:32-38, 1997
41. Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV: Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes. Mol Cell Biol 23:7068-7081, 2003
42. Lang W, Wang H, Ding L, Xiao L: Cooperation between PKC-alpha and PKC-epsilon in the regulation of JNK activation in human lung cancer cells. Cell Signal 16:457-467, 2004